title: Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States.
authors.forename: Jacques
authors.initials: J
authors.lastname: Simkins
authors.forename: Ji
authors.initials: J
authors.lastname: Fan
authors.forename: Jose F
authors.initials: JF
authors.lastname: Camargo
authors.forename: Laura
authors.initials: L
authors.lastname: Aragon
authors.forename: Corey
authors.initials: C
authors.lastname: Frederick
mesh_terms: D061605:Administration, Intravenous; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D017809:Fatal Outcome; D005578:Fosfomycin / Q000008:administration & dosage*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy*; D007711:Klebsiella pneumoniae; D016031:Liver Transplantation; D008875:Middle Aged; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin